Publications

(2025). Effect modification and non-collapsibility together may lead to conflicting treatment decisions: A review of marginal and conditional estimands and recommendations for decision-making. In press, Research Synthesis Methods.
(2024). Estimands and their implications for evidence synthesis for oncology: A case study of treatment switching in meta-analysis.
(2024). The ICH E9 (R1) Estimand Framework in the Context of Real-World Data and Observational Studies. In Pharmacoepidemiology and Drug Safety, 33(1).
(2024). Transportability of model-based estimands in evidence synthesis. Statistics in Medicine, 43(22).
(2024). Broad versus narrow research questions in evidence synthesis: A parallel to (and plea for) estimands. Research Synthesis Methods 15(5).
(2024). Estimands and Strategies for Handling Treatment Switching As an Intercurrent Event in Evidence Synthesis of Randomized Clinical Trials in Oncology. In Value in Health, 27(6).
(2024). Model-based standardization using multiple imputation. BMC Medical Research Methodology, 24(1).
(2023). Estimands in Health Technology Assessments - Methodological Considerations and Recommendations. In Value in Health, 26(12).
(2023). Methodological considerations for novel approaches to covariate-adjusted indirect treatment comparisons. Research Synthesis Methods, 14(4).
(2022). Target estimands for population-adjusted indirect comparisons. Statistics in Medicine, 41(28).